Awaiting Breakthrough for Uptrend–Sunzen Biotech

Sunzen Biotech (KLSE: 0148) is poised for a breakout for the continued uptrend beyond RM0.350, the key resistance level for the company. Both MA20/50 showed positive strengths with reduced selling pressure. Key support remained at RM0.345, which was formed after multi tests on the consolidation phase. Maintain BUY for Sunzen Biotech.

Support: RM0.345, RM0.320

Resistance: RM0.350, RM0.370